Aortic Valve Stenosis
474
77
121
195
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
49 trials with published results (10%)
Research Maturity
195 completed trials (41% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.7%
27 terminated out of 474 trials
87.8%
+1.3% vs benchmark
8%
40 trials in Phase 3/4
25%
49 of 195 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 195 completed trials
Clinical Trials (474)
A Prospective, Multi-centre, Single Arm, Pivotal Clinical Study to Determine the Safety and Effectiveness of Crea Aortic Valve for Use as a Replacement Aortic Heart Valve
Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
Transcatheter Aortic Valve Implantation: Comparison of the Effects of Ultrasound-Guided Pericapsular Nerve Group Block and Fascia Iliaca Block on Postoperative Analgesia Management
Supra-Annular vs. Annular ValvEs for Small Annuli
Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression
CHATEAU Registry: Clinical Outcomes After Transcatheter Aortic Valve Replacement
Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation
Post-Dilatation in Balloon-Expandable TAVI Prostheses
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI)
Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication
TAVI Without Balloon Predilatation (of the Aortic Valve ) SAPIEN 3
Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort
Impact of Trans-catheter Aortic Valve Implantation on Renal Function
Prospective Neuropsychological Evaluation of the Implementation of a Heart Valve Unit (HVU-NEURO)
SMall Annuli Randomized To Evolut™ or SAPIEN™ Trial
Smartphone Based Digital Screening for Aortic Valve Stenosis